Sakuraba, Hitoshi
Togawa, Tadayasu
Tsukimura, Takahiro
Kato, Hiroshi
Funding for this research was provided by:
Dainippon Sumitomo Pharma
Japan Society for the Promotion of Science (15K09606)
Article History
Received: 14 October 2017
Accepted: 17 December 2017
First Online: 29 December 2017
Compliance with ethical standards
:
: This study was supported by Sumitomo Dainippon Pharma Co., Ltd. (SDP) and the Japan Society for the Promotion of Science (ID: 15K09606, HS). These were used solely for research activity. Although H. Kato is an employee of SDP, he has no competing interest. We declare that none of the authors have any competing interest.
: This study was approved by the ethical committees of Meiji Pharmaceutical University (IDs 2616 and 2617) and Sumitomo Dainippon Pharma Co., Ltd. (IDs 2015-02 and 2015-03), and was performed according to the ethical guidelines of the 1975 Declaration of Helsinki. The institutional review board or independent ethics committee at each hospital also approved the study.
: This study has been registered in UMIN (IDs 000016854 and 000017152).
: All participants and/or their parents provided written informed consent or assent.